tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
FRANKFURT:61MA
Germany Market
Advertisement

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is 4.55, suggesting MedCap AB is a Sell.
MedCap AB’s (61MA) 20-Day exponential moving average is 51.11, while MedCap AB’s (61MA) share price is €58, making it a Buy.
MedCap AB’s (61MA) 50-Day exponential moving average is 45.56, while MedCap AB’s (61MA) share price is €58, making it a Buy.

MedCap AB (61MA) Pivot Points

Aug 03, 2025, 10:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
59.40
59.40
59.40
59.40
59.40
59.40
59.40
Fibonacci
59.40
59.40
59.40
59.40
59.40
59.40
59.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

Aug 03, 2025, 10:01 AM
Period
Simple
Exponential
MA5
58.22Sell
57.41Buy
MA10
54.28Buy
54.95Buy
MA20
49.97Buy
51.11Buy
MA50
43.44Buy
45.56Buy
MA100
39.52Buy
42.48Buy
MA200
41.43Buy
42.70Buy
MedCap AB’s (61MA) 10-Day exponential moving average is 54.95, while MedCap AB’s (61MA) share price is €58, making it a Buy.
MedCap AB’s (61MA) 100-Day exponential moving average is 42.48, while MedCap AB’s (61MA) share price is €58, making it a Buy.
MedCap AB’s (61MA) stock price is €58 and MedCap AB’s (61MA) 50-day simple moving average is 43.44, creating a Buy signal.
MedCap AB’s (61MA) stock price is €58 and MedCap AB’s (61MA) 100-day simple moving average is 39.52, creating a Buy signal.
MedCap AB’s (61MA) stock price is €58 and MedCap AB’s (61MA) 200-day simple moving average is 41.43, creating a Buy signal.

MedCap AB (61MA) Technical Indicators

Aug 03, 2025, 10:01 AM
Name
Value
Implied Action
RSI (14)
76.47
Sell
STOCH (9,6)
92.99
Sell
STOCHRSI (14)
93.32
Sell
MACD (12,26)
4.55
Sell
ADX (14)
48.26
Neutral
Williams %R
-10.41
Sell
CCI (14)
101.81
Sell
ATR (14)
1.28
-
Ultimate Oscillator
82.03
Buy
ROC
23.93
Buy
MedCap AB’s (61MA) Relative Strength Index (RSI) is 76.47, creating a Sell signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 48.26, creating a Neutral signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is 101.81, creating a Sell signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is 23.93, creating a Buy signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Buy.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 76.47, which suggests 61MA is a Sell.
      What is 61MA’s MACD?
      61MA’s MACD is 4.55, which suggests 61MA is a Sell.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 58.22, which suggests 61MA is a Sell.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 49.97, which suggests 61MA is a Buy.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 43.44, which suggests 61MA is a Buy.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 41.43, which suggests 61MA is a Buy.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -10.41, which suggests 61MA is a Sell.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is 101.81, which suggests 61MA is a Sell.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis